Clinical trial
Safety and Efficacy Study of Photopheresis With UVADEX to Prevent…
NCT00054600 · Mallinckrodt, Industry · Completed
Key facts
| NCT number | NCT00054600 |
|---|---|
| Title | Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease |
| Official title | A Study of Extracorporeal Photopheresis With UVADEX in the Setting of a Standard Myeloablative Conditioning Regimen for the Prevention of Graft-versus-Host Disease in Patients Undergoing an Allogeneic Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant |
| Lead sponsor | Mallinckrodt, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft-versus-Host Disease |
| Intervention type | Drug, Procedure |
| Interventions | Methoxsalen, Extracorporeal Photopheresis |
| Enrollment | 60 |
| Start date | Jun 1, 2002 |
| Completion | Jun 1, 2004 |
| First posted | Feb 6, 2003 |
| Last update posted | Aug 16, 2017 |
| Countries | Australia, Brazil, Germany, Italy, Portugal, Slovakia, Turkey (Türkiye), United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: